Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $957M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 9,426,640 | $101M | 10.5% | $9.11 | +32.9% | SHS | G72800108 |
| XNCR | XENCOR INC | 2,501,557 | $74.75M | 7.8% | $35.02 | -5.4% | COM | 98401F105 |
| ARVN | ARVINAS INC | 1,528,031 | $61.58M | 6.4% | $31.44 | +48.8% | COM | 04335A105 |
| — | DICERNA PHARMACEUTICALS INC | 3,346,301 | $61.47M | 6.4% | $10.37 | — | COM | 253031108 |
| FATE | FATE THERAPEUTICS INC | 2,341,875 | $52.01M | 5.4% | $23.48 | +7.7% | COM | 31189P102 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 4,393,236 | $44.33M | 4.6% | $11.82 | -0.6% | COM CL A | 46333X108 |
| ANAB | ANAPTYSBIO INC | 3,036,014 | $42.9M | 4.5% | $20.66 | -26.6% | COM | 032724106 |
| — | NEOLEUKIN THERAPEUTICS INC | 3,693,203 | $42.03M | 4.4% | $6.84 | — | COM | 64049K104 |
| — | MORPHIC HLDG INC | 2,823,141 | $41.44M | 4.3% | $18.60 | — | COM | 61775R105 |
| — | ASSEMBLY BIOSCIENCES INC | 2,590,680 | $38.42M | 4.0% | $19.62 | — | COM | 045396108 |
| KURA | KURA ONCOLOGY INC | 3,511,690 | $34.94M | 3.7% | $11.06 | +3.5% | COM | 50127T109 |
| — | FIBROGEN INC | 882,138 | $30.65M | 3.2% | $43.99 | — | COM | 31572Q808 |
| IPHA | INNATE PHARMA S A | 4,465,668 | $29.83M | 3.1% | $6.44 | — | SPONSORED ADS | 45781K204 |
| — | MIRATI THERAPEUTICS INC | 357,849 | $27.51M | 2.9% | $76.98 | — | COM | 60468T105 |
| — | PREVAIL THERAPEUTICS INC | 2,248,306 | $27.41M | 2.9% | $13.20 | — | COM | 74140Y101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 2,536,156 | $21.41M | 2.2% | $9.72 | 0.0% | COM | 74587V107 |
| — | MERUS N V | 1,715,962 | $20.76M | 2.2% | $14.44 | — | COM | N5749R100 |
| — | ATRECA INC | 1,106,180 | $18.31M | 1.9% | $18.84 | — | CL A COM | 04965G109 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 371,208 | $16.49M | 1.7% | $47.04 | +10.4% | COM | 90400D108 |
| SGMO | SANGAMO THERAPEUTICS INC | 2,308,079 | $14.7M | 1.5% | $7.42 | 0.0% | COM | 800677106 |
| GMAB | GENMAB A/S | 653,981 | $13.86M | 1.4% | $21.19 | — | SPONSORED ADS | 372303206 |
| ACAD | ACADIA PHARMACEUTICALS INC | 323,889 | $13.68M | 1.4% | $43.50 | -5.3% | COM | 004225108 |
| DNLI | DENALI THERAPEUTICS INC | 698,101 | $12.22M | 1.3% | $20.86 | 0.0% | COM | 24823R105 |
| FOLD | AMICUS THERAPEUTICS INC | 1,249,611 | $11.55M | 1.2% | $9.51 | 0.0% | COM | 03152W109 |
| — | SELECTA BIOSCIENCES INC | 4,597,701 | $11.08M | 1.2% | $2.38 | — | COM | 816212104 |
| IONS | IONIS PHARMACEUTICALS INC | 208,609 | $9.863M | 1.0% | $55.74 | 0.0% | COM | 462222100 |
| VIR | VIR BIOTECHNOLOGY INC | 270,418 | $9.267M | 1.0% | $26.88 | 0.0% | COM | 92764N102 |
| — | ZIOPHARM ONCOLOGY INC | 3,750,000 | $9.188M | 1.0% | $2.45 | — | COM | 98973P101 |
| — | VERASTEM INC | 3,255,813 | $8.595M | 0.9% | $2.64 | — | COM | 92337C104 |
| — | BRISTOL-MYERS SQUIBB CO | 2,248,300 | $8.544M | 0.9% | $3.80 | — | RIGHT 99/99/9999 | 110122157 |
| — | CYCLERION THERAPEUTICS INC | 2,742,276 | $7.267M | 0.8% | $5.17 | — | COM | 23255M105 |
| — | CHIASMA INC | 1,512,627 | $5.521M | 0.6% | $5.00 | — | COM | 16706W102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 350,000 | $5.145M | 0.5% | $20.50 | 0.0% | COM | 22663K107 |
| — | EXICURE INC | 2,841,301 | $4.205M | 0.4% | $2.53 | — | COM | 30205M101 |
| RCUS | ARCUS BIOSCIENCES INC | 292,100 | $4.054M | 0.4% | $14.43 | -13.8% | COM | 03969F109 |
| SVRA | SAVARA INC | 1,432,664 | $3.037M | 0.3% | $1.20 | +127.8% | COM | 805111101 |
| — | LIFESCI ACQUISITION CORP | 300,000 | $3M | 0.3% | $10.00 | — | UNIT 03/31/2025 | 53228P208 |
| — | SURFACE ONCOLOGY INC | 1,274,463 | $2.383M | 0.2% | $10.23 | — | COM | 86877M209 |
| ACRS | ACLARIS THERAPEUTICS INC | 2,087,312 | $2.171M | 0.2% | $1.66 | -17.9% | COM | 00461U105 |
| CRVS | CORVUS PHARMACEUTICALS INC | 737,612 | $1.556M | 0.2% | $3.50 | +16.1% | COM | 221015100 |
| — | ZYMEWORKS INC | 41,407 | $1.469M | 0.2% | $35.48 | — | COM | 98985W102 |
| CRSP | CRISPR THERAPEUTICS AG | 30,510 | $1.294M | 0.1% | $51.63 | 0.0% | NAMEN AKT | H17182108 |
| MGTX | MEIRAGTX HOLDINGS PLC | 94,819 | $1.274M | 0.1% | $16.89 | 0.0% | COM | G59665102 |
| — | TRILLIUM THERAPEUTICS INC | 291,997 | $1.18M | 0.1% | $4.04 | — | COM NEW | 89620X506 |
| XOMA | XOMA CORP DEL | 50,809 | $1.034M | 0.1% | $23.09 | 0.0% | COM NEW | 98419J206 |
| — | REGULUS THERAPEUTICS INC | 1,886,812 | $870K | 0.1% | $0.46 | — | COM NEW | 75915K200 |
| — | BLUEPRINT MEDICINES CORP | 13,946 | $816K | 0.1% | $58.51 | — | COM | 09627Y109 |
| — | PIERIS PHARMACEUTICALS INC | 264,166 | $602K | 0.1% | $3.62 | — | COM | 720795103 |
| — | FIVE PRIME THERAPEUTICS INC | 256,075 | $581K | 0.1% | $2.27 | — | COM | 33830X104 |
| EXEL | EXELIXIS INC | 6,269 | $108K | 0.0% | $18.29 | 0.0% | COM | 30161Q104 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,101 | $8,000 | 0.0% | $6.75 | +3.3% | COM | 23284F105 |